The cloud-hosted eGMS® software-as-a-service (SaaS) solution will be used enterprise-wide, across all of Palmetto Health’s clinical disciplines.
“Palmetto Health selected the Glytec system because they feel it is well aligned with their patient care and quality initiatives,” says Glytec’s Chief Medical Officer, Andrew S. Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC. “The Glytec system has the potential to positively impact patient populations served under their ACO and value-based programs.”
Users will access the eGMS® directly from Palmetto Health’s Cerner Millenium system via SmartClick®, which allows for seamless EMR integration, including single sign-on.
The eGMS® centers on Glucommander™, an FDA-cleared Class II medical device for real-time intravenous and subcutaneous insulin dosing. Computerized, evidence-based algorithms ensure that dosing recommendations produced by Glucommander™ align with — and continually adjust to — each patient’s unique insulin sensitivities.
Through continuous, facility-wide surveillance and analysis of blood glucose levels, the eGMS® module, GlucoSurvelliance®, will identify and flag potential candidates for insulin therapy.
Given 30-40% of hospitalized patients require insulin therapy, GlucoSurvelliance® will help ensure that clinical care teams throughout Palmetto Health perform patient evaluations and start treatments in a timely manner. GlucoSurvelliance® will interface directly with the laboratory information system (LIS).
Additionally, the analytics and reporting capabilities of the eGMS® module, GlucoMetrics®, will offer clinicians, administrators and executives a means to measure and monitor key performance indicators and other metrics.
Glytec’s clinical services organization will work with Palmetto Health to establish best practices and standards of care for glycemic management, and to optimize the eGMS® around targeted outcomes.
Glytec’s Vice President of Clinical Practice, Melanie Mabrey, DNP, ACNP-BC, BC-ADM, CDTC, FAANP, notes, “Managing patients’ glucose levels can be challenging for clinical care teams, especially with limited endocrinology resources. With the Glytec system, diabetes educators and nurses will have greater confidence in treating patients on insulin therapy, and will be more productive.”
